Clinical Trial Update: Aspirin for the Treatment of Nonalcoholic Fatty Liver Disease [Phase 1, Phase 2]

View source ↗

Summary

Aspirin is being studied for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in Phase 1/2. The trial is completed, and results were posted on …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease
• Nonalcoholic Steatohepatitis

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Nonalcoholic Fatty Liver, Nonalcoholic Steatohepatitis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-05-24